As more doses of the COVID-19 vaccine become available in the US, communities across the country have begun encountering vaccine hesitancy – sectors of the population that have access to doses but that express doubts, skepticism, or concerns. The ability to understand where that hesitancy comes from, and how to address it, could mean the difference between achieving herd immunity early or enduring many more months of the pandemic.